◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CC

Chemours Co (CC) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · SPECIALTY CHEMICALS · DATA UPDATED 2026-09-06

Chemours Co (CC) operates in the SPECIALTY CHEMICALS industry and is headquartered in Wilmington, United States with about 5,700 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, CC reported $5.8B in revenue and ($386M) in net income.

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

Interactive charts & full statements → Open the CC valuation workbench →

CC Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Total Revenue$5.8B$5.8B$5.8B$6.1B$6.8B$6.3B$5.0B$5.5B$6.6B$6.2B$5.4B$5.7B$6.4B$6.9B$7.4B$8.0B
Gross Profit$889M$902M$1.2B$1.3B$1.6B$1.4B$1.1B$1.1B$2.0B$1.8B$1.1B$955M$1.4B$1.5B$2.4B$2.6B
Gross Margin %15.3%15.5%19.9%21.5%23.7%21.8%21.5%19.2%29.7%28.4%20.6%16.7%21.1%21.3%31.9%32.6%
Operating Income (EBIT)($304M)($5M)$443M($123M)$786M$674M$448M$447M$1.2B$1.1B$96M$226M$532M$532M$1.5B$1.7B
Operating Margin %-5.2%-0.1%7.7%-2.0%11.5%10.6%9.0%8.1%18.6%17.3%1.8%4.0%8.3%7.8%19.8%21.7%
Net Income($304M)($386M)$86M($238M)$578M$608M$219M($52M)$995M$746M$7M($90M)$400M$423M$1.1B$1.4B
Net Margin %-5.2%-6.7%1.5%-3.9%8.5%9.6%4.4%-0.9%15.0%12.1%0.1%-1.6%6.2%6.2%14.3%17.9%
EBITDA($166M)$332M$692M$197M$1.2B$1.2B$767M$715M$1.5B$1.3B$715M$211M$789M$793M$1.7B$2.0B
Earnings Per Share (EPS)$-2.01$-2.56$0.57$-1.60$3.65$3.60$1.32$-0.32$5.45$3.91$0.04$-0.50$2.19$2.31$5.78$7.83
Shares Outstanding (M)151M151M150M149M158M169M166M165M183M191M183M181M183M183M183M183M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$1.6B$1.4B$1.3B$1.5B$1.6B$1.4B$1.4B$1.5B
Gross Profit$286M$215M$153M$235M$278M$236M$273M$286M
Gross Margin %18.0%15.6%11.5%15.7%17.2%17.2%19.6%19.1%
Operating Income (EBIT)($213M)$64M($259M)$104M$72M$78M$75M$122M
Operating Margin %-13.4%4.6%-19.5%7.0%4.5%5.7%5.4%8.1%
Net Income($274M)($29M)($61M)$60M($381M)($4M)($8M)($27M)
Net Margin %-17.2%-2.1%-4.6%4.0%-23.6%-0.3%-0.6%-1.8%
EBITDA($413M)$125M($76M)$198M($115M)$154M$154M$117M
Earnings Per Share (EPS)$-1.81$-0.19$-0.41$0.40$-2.54$-0.03$-0.05$-0.18
Shares Outstanding (M)151M151M151M150M150M150M150M150M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CC Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Cash from Operations (CFO)$353M$264M($633M)$556M$754M$820M$807M$650M$1.1B$639M$594M$182M$505M$798M$1.4B$1.5B
Capital Expenditures (CapEx)$228M$213M$360M$370M$307M$277M$267M$481M$498M$411M$338M$519M$604M$438M$432M$355M
Free Cash Flow (FCF)$125M$51M($993M)$186M$447M$543M$540M$169M$642M$228M$256M($337M)($99M)$360M$958M$1.1B
FCF Margin %2.2%0.9%-17.2%3.1%6.5%8.6%10.9%3.1%9.7%3.7%4.7%-5.9%-1.5%5.2%13.0%14.3%
Dividends Paid$67M$78M$148M$149M$154M$164M$164M$164M$148M$22M$22M$105M$105M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CC Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$114M($44M)$137M$146M$93M($112M)$138M$139M
Capital Expenditures (CapEx)$93M$49M$45M$41M$43M$84M$109M$76M
Free Cash Flow (FCF)$21M($93M)$92M$105M$50M($196M)$29M$63M
FCF Margin %1.3%-6.7%6.9%7.0%3.1%-14.3%2.1%4.2%
Dividends Paid$26M$13M$15M$13M$13M$37M$36M$38M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CC Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Total Assets$7.2B$7.4B$7.5B$8.3B$7.6B$7.5B$7.1B$7.3B$7.4B$7.3B$6.1B$6.3B$6.0B$5.6B$5.3B
Cash & Cash Equivalents$671M$672M$713M$1.2B$1.1B$1.5B$1.1B$943M$1.2B$1.6B$902M$366M$366M
Total Liabilities$7.2B$7.1B$6.9B$7.5B$6.5B$6.5B$6.3B$6.6B$6.3B$6.4B$6.0B$6.2B$2.3B$2.3B$2.1B
Total Debt (Short + Long-Term)$3.9B$4.2B$4.2B$4.1B$3.7B$3.8B$4.1B$4.2B$3.9B$4.0B$3.5B$4.0B$262M$333M$250M
Total Shareholders' Equity($49M)$250M$604M$737M$1.1B$1.1B$813M$689M$1.0B$860M$100M$126M$3.7B$3.3B$3.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CC viewer.

Other Companies in SPECIALTY CHEMICALS

← CBZAll “C” companiesCC1U →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.